<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(1)</volume><submitter>Verheul EM</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Comparison of quality indicators can improve quality of care. However, case-mix adjustment is deemed essential. The aim of this study was to develop and validate case-mix adjustment models and to evaluate the effect of case-mix adjustment for the quality indicators related to complications after breast cancer surgery.&lt;h4>Methods&lt;/h4>Multivariable logistic regression with backward selection (P &lt; 0.1) was used to develop case-mix models in patients undergoing breast cancer surgery (all types, breast-conserving surgery, mastectomy with or without immediate reconstruction) in the Netherlands (NABON Breast Cancer Audit). High-impact complications were defined as Clavien Dindo grade ≥3. Model performance was assessed using the area under the receiver operating characteristic c</pubmed_abstract><journal>BJS open</journal><pagination>zrae147</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11793075</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High-impact complications after breast cancer surgery in the Dutch national quality registry: evaluating case-mix adjustment for hospital comparisons.</pubmed_title><pmcid>PMC11793075</pmcid><pubmed_authors>Paez CG</pubmed_authors><pubmed_authors>van Hezewijk M</pubmed_authors><pubmed_authors>Dols LFC</pubmed_authors><pubmed_authors>Schok T</pubmed_authors><pubmed_authors>van Uden DJP</pubmed_authors><pubmed_authors>Vissers YLJ</pubmed_authors><pubmed_authors>Koppert LB</pubmed_authors><pubmed_authors>Van Dessel E</pubmed_authors><pubmed_authors>Schoenmaeckers EJP</pubmed_authors><pubmed_authors>Volders JH</pubmed_authors><pubmed_authors>den Hoed DM</pubmed_authors><pubmed_authors>Bijlsma RM</pubmed_authors><pubmed_authors>Lans TE</pubmed_authors><pubmed_authors>Menke-Pluijmers MBE</pubmed_authors><pubmed_authors>Francken AB</pubmed_authors><pubmed_authors>Heijns JB</pubmed_authors><pubmed_authors>Neijenhuis PA</pubmed_authors><pubmed_authors>Lingsma HF</pubmed_authors><pubmed_authors>van Klaveren D</pubmed_authors><pubmed_authors>van der Vegt B</pubmed_authors><pubmed_authors>Kappers I</pubmed_authors><pubmed_authors>Siesling S</pubmed_authors><pubmed_authors>Rakhorst HA</pubmed_authors><pubmed_authors>Frakking TG</pubmed_authors><pubmed_authors>Loo CE</pubmed_authors><pubmed_authors>Schipper RJ</pubmed_authors><pubmed_authors>Tjan-Heijnen VCG</pubmed_authors><pubmed_authors>Hellingman AA</pubmed_authors><pubmed_authors>Vos E</pubmed_authors><pubmed_authors>Meijer J</pubmed_authors><pubmed_authors>Damen THC</pubmed_authors><pubmed_authors>Martens MH</pubmed_authors><pubmed_authors>Vrancken Peeters MTFD</pubmed_authors><pubmed_authors>Beek MA</pubmed_authors><pubmed_authors>van Sprundel TC</pubmed_authors><pubmed_authors>Bantema-Joppe EJ</pubmed_authors><pubmed_authors>NBCA consortium</pubmed_authors><pubmed_authors>Verbeek FPR</pubmed_authors><pubmed_authors>Henneman D</pubmed_authors><pubmed_authors>van Engelen K</pubmed_authors><pubmed_authors>van den Hoven I</pubmed_authors><pubmed_authors>Hoven-Gondrie ML</pubmed_authors><pubmed_authors>Gordinou de Gouberville MC</pubmed_authors><pubmed_authors>Contant CME</pubmed_authors><pubmed_authors>Straver ME</pubmed_authors><pubmed_authors>de Betue CTI</pubmed_authors><pubmed_authors>Siemerink E</pubmed_authors><pubmed_authors>Schlooz-Vries M</pubmed_authors><pubmed_authors>Schuttevaer H</pubmed_authors><pubmed_authors>Moorman AM</pubmed_authors><pubmed_authors>de Munck L</pubmed_authors><pubmed_authors>Verheul EM</pubmed_authors><pubmed_authors>Verloop J</pubmed_authors><pubmed_authors>Van Bastelaar J</pubmed_authors><pubmed_authors>Hoornweg MJ</pubmed_authors><pubmed_authors>Gooiker GA</pubmed_authors><pubmed_authors>Beelen KJ</pubmed_authors><pubmed_authors>Bessems M</pubmed_authors><pubmed_authors>van Deurzen CHM</pubmed_authors><pubmed_authors>van Eekeren RRJP</pubmed_authors><pubmed_authors>Jansen P</pubmed_authors><pubmed_authors>Meeuwis C</pubmed_authors><pubmed_authors>Bosscher MRF</pubmed_authors></additional><is_claimable>false</is_claimable><name>High-impact complications after breast cancer surgery in the Dutch national quality registry: evaluating case-mix adjustment for hospital comparisons.</name><description>&lt;h4>Background&lt;/h4>Comparison of quality indicators can improve quality of care. However, case-mix adjustment is deemed essential. The aim of this study was to develop and validate case-mix adjustment models and to evaluate the effect of case-mix adjustment for the quality indicators related to complications after breast cancer surgery.&lt;h4>Methods&lt;/h4>Multivariable logistic regression with backward selection (P &lt; 0.1) was used to develop case-mix models in patients undergoing breast cancer surgery (all types, breast-conserving surgery, mastectomy with or without immediate reconstruction) in the Netherlands (NABON Breast Cancer Audit). High-impact complications were defined as Clavien Dindo grade ≥3. Model performance was assessed using the area under the receiver operating characteristic c</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2025-04-04T07:26:23.432Z</modification><creation>2025-04-04T07:26:23.432Z</creation></dates><accession>S-EPMC11793075</accession><cross_references><pubmed>39903734</pubmed><doi>10.1093/bjsopen/zrae147</doi></cross_references></HashMap>